Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway

Fig. 5

CD58 and sCD58 induced cancer cell stemness of HCC cells. a, b CD58 knockdown impaired sphere-forming capacity in Huh7 (a) and SK-Hep-1 (b) cells. c Effects of sCD58 on sphere-forming capacity in Huh7 cell. d Correlation of CD58 with cancer stemness markers by analyzing the TIMER database. e Western blotting analysis of Oct4, Sox2, CD24, and EPCAM protein levels in the indicated cells (n = 3)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us